Several active research areas include: Metabolic dysfunction-associated steatotic liver disease (MASLD) : Multiple trials are evaluating semaglutide's effects on liver fat content and biomarkers, with preliminary data suggesting potential benefits in reducing hepatic steatosis and improving liver enzyme profiles Chronic kidney disease : Studies examining renal outcomes in patients with type 2 diabetes and established kidney disease, building on secondary analyses from SUSTAIN 6 showing reduced progression of diabetic nephropathy Obstructive sleep apnea : Ongoing trials investigating whether weight loss achieved with semaglutide improves sleep apnea severity and related cardiovascular outcomes Addiction and substance use disorders : Early-phase research exploring GLP-1 receptor agonists' potential effects on reward pathways and addictive behaviors, though this remains highly preliminary Alzheimer's disease and cognitive function : Preclinical evidence suggesting neuroprotective properties has prompted clinical trials examining cognitive outcomes in at-risk populations Researchers are also investigating combination therapies , such as cagrilintide plus semaglutide (CagriSema), which is currently under development
Whats Included in Sesame Care GLP-1
In clinical trials, nausea rates reached 44 percent at the highest Wegovy dose
Many Miami-based clinics provide free consultations, allowing you to explore your options before committing to a treatment plan.
Standard GI research endpoints include: macroscopic damage scoring (CDAI-equivalent scales in IBD models), histological assessment (H&E staining, villus/crypt morphometry), tight junction protein expression (Western blot, immunofluorescence), permeability assays (FITC-dextran, Ussing chambers), and inflammatory cytokine panels
